Peter Repiščák
Impact in
-
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
-
- Metabolism, Diabetes, and Cancer
- Peroxisome Proliferator-Activated Receptors
- Mitochondrial Function and Pathology
Papers in ⓘ
-
- Epigenetics and DNA Methylation 2
- CRISPR and Genetic Engineering 2
- Single-cell and spatial transcriptomics 1
- Metabolism, Diabetes, and Cancer 1
- Protein Degradation and Inhibitors 1
-
- Prostate Cancer Treatment and Research 6
- Co-authors
- Martin J. Paterson (4 shared papers)Stefan Erhardt (3 shared papers)Graham Rena (2 shared papers)I. Galbraith (1 shared paper)Hing Y. Leung (5 shared papers)Rachana Patel (6 shared papers)Mark J. Salji (4 shared papers)Ernest Mui (4 shared papers)
- Journals
- iScience (1 paper)Clinical Cancer Research (1 paper)Cancers (1 paper)ACS Omega (1 paper)Science Immunology (1 paper)
- Partner nations
- United KingdomAustriaFinland
In The Last Decade
Peter Repiščák
13 papers receiving 396 citations
Peers
Comparison fields: 5 of 80
- Cancer Research 105
- Molecular Biology 225
- Aging 5
- Biochemistry 14
- Immunology 40
Countries citing papers authored by Peter Repiščák
This map shows the geographic impact of Peter Repiščák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Repiščák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Repiščák more than expected).
Fields of papers citing papers by Peter Repiščák
This network shows the impact of papers produced by Peter Repiščák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Repiščák. The network helps show where Peter Repiščák may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Repiščák, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 117 | |
| 2 | 2016 | 87 | |
| 3 | 2016 | 44 | |
| 4 | 2014 | 43 | |
| 5 | 2021 | 23 | |
| 6 | 2018 | 21 | |
| 7 | 2021 | 20 | |
| 8 | 2020 | 17 | |
| 9 | 2020 | 14 | |
| 10 | 2022 | 8 | |
| 11 | 2022 | 6 | |
| 12 | Targeting cholesterol transport in castration-resistant prostate cancer | 2018 | 1 |
| 13 | 2025 | 1 |
About Peter Repiščák
Peter Repiščák is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Oncology and Surgery, having authored 13 papers that have together received 402 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (6 papers), Cancer, Lipids, and Metabolism (4 papers), Epigenetics and DNA Methylation (2 papers), CRISPR and Genetic Engineering (2 papers), Pancreatic function and diabetes (1 paper), Single-cell and spatial transcriptomics (1 paper), Metabolism, Diabetes, and Cancer (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Cancer Research (105 citations), Molecular Biology (225 citations), Aging (5 citations), Biochemistry (14 citations) and Immunology (40 citations). Peter Repiščák has collaborated with scholars based in United Kingdom, Austria and Finland. Frequent co-authors include Martin J. Paterson, Stefan Erhardt, Graham Rena, I. Galbraith, Hing Y. Leung, Rachana Patel, Mark J. Salji, Ernest Mui, Lisa Logie and Calum Forteath. Their work appears in journals such as iScience, Clinical Cancer Research, Cancers, ACS Omega and Science Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.